Postmarket Surveillance Activity Linked To Device User Fee Proposal
The possibility of medical device user fees eventually funding CDRH postmarket surveillance activity is raised in a provision of the "Medical Device User Fee & Modernizaton Act" of 2002
More from Archive
More from Medtech Insight
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
HHS and its agencies violated the law by swiftly implementing “sweeping and poorly thought-through directives that ordered the bulk removal of healthcare resources,” including FDA draft guidances on diversity action plans and sex differences in clinical trials, a federal court said.
The US FDA needs to know who wants a seat at the MDUFA negotiations table before discussions can begin. The agency is asking stakeholders to let it know if they plan to participate in the periodic consultation meetings before July 28.